Hyperspectral imaging for contactless diagnosis of intraepithelial and invasive neoplasias

Hyperspectral imaging for contactless diagnosis of intraepithelial and invasive neoplasias - Hyperspectral

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00013486

Enrollment

100

Registered

2017-12-05

Start date

2017-12-19

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraepithelial and invasive neoplasms N87

Interventions

Group 1: hyperspectral imaging of intraepithelial or invasive neoplasia of the female reproductive organs

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: • Clinical / histological evidence of intraepithelial or invasive neoplasia • Written agreement after clarification

Exclusion criteria

Exclusion criteria: missing signed informed agreement

Design outcomes

Primary

Measure	Time frame
Determination of specificity and sensitivity of hyperspectral imaging	—

Secondary

Measure	Time frame
Estimate the specificity and sensitivity of the iodine-acid analyses in this collective for comparison. Estimation of the positive and negative predictive value of hyperspectral imaging	—

Countries

Germany

Contacts

Public ContactMartin Weiss

Department für Frauengesundheit

martin.weiss@med.uni-tuebingen.de070712982211

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026